PharmaBoardroom

Interview with Charles Woler, CEO, Endotis Pharma

Endotis was incorporated in 2003 on the basis of a technology transfer from on a French public research institution. Can you elaborate on the origins?…

Interview with Arnim Jost, General manager, Cegedim Deutschland…

You joined Cegedim in summer 2006 eleven months before its merger with Dendrite in 2007 that created the world leader in pharmaceutical CRM. How would…

Interview with Jean De Szolnok, President, Boehringer Ingelheim…

There is a lot of change occurring in the French pharmaceutical industry at the moment and this is no different for Boehringer Ingelheim. Just last…

Interview with Eric Zwisler, CEO of Zuellig Pharma Asia Pacific,…

You started the Chinese operations and have been working in the country for many years but recently moved up to running all operations in Asia…

Interview with Boudewijn Van Bochove , CEO, Biogen Idec Germany

Having experienced many years at big pharmaceutical companies, you recently moved into the booming biotech sector by joining Biogen Idec in 2007. What…

Interview with Gernot Köhler, CEO and Owner, Dr. F. Köhler…

Your father was the founder of Dr. Franz Köhler Chemie – that carries his name – and was a very well respected doctor among the German medical…

Interview with Philippe Lamoureux, LEEM – Les Enterprises…

What are the main tasks of the LEEM? The LEEM is the only professional organization representing the pharmaceutical industry in France. It…

Interview with Catherine Bourrienne-Bautista, Managing Director,…

Generic drugs were a very late arrival for the French market in comparison with other European markets and healthcare systems on a par with the French…

Interview with Jean-Pierre Cassan, Honrary President of the LEEM,…

Throughout your prolific career in the pharmaceutical industry, what would you describe have been the major changes in the French pharmaceutical…

Interview with Martin Stapf, Global BU Director Oncology, Hikma…

One of the biggest recent milestones for Hikma’s global operations must have been the acquisition of Ribosepharm and Thymoorgan in 2007. How…

Interview with Klaus Heumann, Founder and CEO, Biomax Informatics

Your interest in bioinformatics has run though your academic career and now into your business career as CEO and founder of Biomax Informatics; what…

Interview with Simon Jose, General Manager UK, GlaxoSmithKline

Given the heated debate over NHS reform and the new revised bill proposed by the government, what are you current priorities as President of the ABPI…

Tagged with M